source
- Latigo's mid-stage trial shows non-opioid pill LTG-001 cuts post-surgery pain, outperforms placeboLatigo Biotherapeutics reported positive Phase 2 data for its experimental oral analgesic LTG-001, tested in patients who had undergone tummy-tuck surgery. The study enrolled 343 participants who w…
- Trump administration ends Medicare drug plan subsidies, raising cost concerns ahead of midtermsThe White House announced that subsidies for private Medicare prescription drug plans will be discontinued, a move expected to increase premiums for many seniors. The policy shift comes as Democra…